TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Human Genome Sciences (NASDAQ:HGSI) Investor Investigation Over Potential Breaches Of Fiduciary Duties In Connection With The Proposed Takeover By GlaxoSmithKline

  • If you purchased shares of Human Genome Sciences (NASDAQ:HGSI) prior to July 13, 2012, and currently hold any of those ASDAQ:HGSI shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

July 16, 2012 (Shareholders Foundation) -- An investigation on behalf of investors in Human Genome Sciences (NASDAQ:HGSI) shares was announced concerning whether the offer by GlaxoSmithKline to acquire Human Genome Sciences at $14.25 per NASDAQ:HGSI share and the takeover process are unfair to investors in NASDAQ:HGSI shares. The investigation by a law firm concerns whether certain o...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: